THERAVANCE BIOPHARMA INC (TBPH) — Congressional trading
Health Care · NASDAQ
THERAVANCE BIOPHARMA INC (TBPH) has 1 reported Congressional stock trading disclosure in our data, including 1 sale among the most recent 1 (latest 2025-03-24).
Reported STOCK-Act stock transactions
| Trade date | Member | Type | Amount range | Filed | Source |
|---|---|---|---|---|---|
| 2025-03-24 | Hon. George Whitesides | Sale | $15,001 – $50,000 | 2025-04-23 | PTR |
Ask the chat about Congressional trading in TBPH →
Source: U.S. House Clerk Periodic Transaction Reports (PTRs) filed under the STOCK Act. Disclosure can lag the actual trade by up to 45 days, so these are not real-time. Amounts are broad ranges as legally required — not exact figures. A transaction may belong to the member, their spouse, or a dependent child (see the owner column); a spouse or dependent trade is not the member's personal trade. This information is reused from the official public disclosure record for informational and public-interest (news) purposes only. Informational only — NOT financial advice, and NOT a signal to buy or sell.
See the full company profile: THERAVANCE BIOPHARMA INC (TBPH).
Last updated 2025-03-24 (most recent disclosed transaction date).
Informational only — NOT financial advice. Congressional disclosures are sourced from the U.S. House Clerk public financial-disclosure archive and shown with their reported dates.